Products

SteadIP

Get a dedicated IP at home — over WireGuard.

steadip.com Security & Privacy / VPN & Privacy Protection

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Maxime Labelle
No social account linked
Launched
9mo ago
2026-02-26 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events2 marketing moves

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Free & awesome HTTP/HTTPS tunnels for your homelab

    Jul 3 · 5mo agoLaunch page

  • Launched on Product HuntLaunch

    Get a dedicated IP at home — over WireGuard.

    Feb 26 · 9mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct34%
  • Organic Search33%
  • Referrals15%
  • Social6%
  • Other12%

Countries

  • Singapore58%
  • Spain40%
  • Colombia3%

Search

Domain authority —Domain registered 2026-02-10

KeywordMonthly volume
ngrok alternative740
localhost world sharing minecraft280
port forwarding without public ip—

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-02-26

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does SteadIP get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is SteadIP and what platforms does it support?
SteadIP is catalogued under VPN & Privacy Protection: Get a dedicated IP at home — over WireGuard.. Supported platforms: Web.

Related products in this category

Security & Privacy / VPN & Privacy Protection

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.